Ensuring Leadership Continuity—The Coleman Health Services Case Study is starting in

Alabama Medicaid Pharmacy Hepatitis C Antiviral Agents Prior Authorization Request Form

The Alabama Medicaid Agency published the form on January 12, 2022. It states that preferred Hepatitis C Antiviral Agents will be considered “preferred with clinical criteria". These agents will require this prior authorization request be submitted. Clinical criteria must be met in order to be approved. Non-preferred products will continue to require prior authorization. For a non-preferred product to be approved, contraindication to preferred agents must exist or the non-preferred agent must be prescribed for a genotype for which all preferred agents are not approved by the U.S. Food and Drug Administration (FDA . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.